1) Real time PCR provides a rapid, sensitive and specific method for diagnosis of infectious diseases compared to conventional methods. It can detect pathogens within 1 hour compared to days or months for cultures.
2) The document discusses various infectious diseases and the recommended tests for their diagnosis. Real time PCR is highlighted as the most effective method for diagnosis of diseases like tuberculosis, hepatitis B, hepatitis C and human papillomavirus.
3) Point-of-care testing using technologies like TrueNat provide portable, easy-to-use and low-cost real time PCR diagnostics that can be used even in remote locations.
Presentation on nested pcr . contain types of pcr, protocol of nested pcr, advantages of nested pcr, disadvantages of nested pcr, application of nested pcr ,pictorial representation of pcr.
Laboratory diagnosis of H. Pylori infection, Ola ElgaddarOla Elgaddar
A short presentation for the different laboratory techniques used in diagnosing Helicobacter Pylori infection. A special focus is given for the diagnostic performance of every test.
Presentation on nested pcr . contain types of pcr, protocol of nested pcr, advantages of nested pcr, disadvantages of nested pcr, application of nested pcr ,pictorial representation of pcr.
Laboratory diagnosis of H. Pylori infection, Ola ElgaddarOla Elgaddar
A short presentation for the different laboratory techniques used in diagnosing Helicobacter Pylori infection. A special focus is given for the diagnostic performance of every test.
Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...QIAGEN
Antibiotic resistant strains of pathogenic bacteria are a growing worldwide health problem. To effectively combat the spread of difficult-to-treat bacterial infections, rapid surveillance methods for detection of antibiotic resistance genes is required to monitor both bacterial isolates and metagenomic samples. Additionally, identification of potential new sources for different antibiotic resistance genes is critical. Both of these goals require tools that can be used for profiling of antibiotic resistance genes from various types of samples. Real-time PCR has proven to be effective for the detection of antibiotic resistance genes. Using PCR array technology, simultaneous detection of 87 prevalent and important antibiotic resistance genes is possible and should prove to be an effective method for antibiotic resistance monitoring. This allows for a more comprehensive profiling of antibiotic resistance genes than is possible using individual PCR assays.
Tuberculosis is a raging problem round the globe. Eradicating TB is a herculean task but is possible is efforts from all corners from the world. The diagnostics have taken a big leap and with effective medications, our dream of TB free world may come true. But unlimited efforts are need to reach our goal.
Diagnostic Medical Microbiology - Traditional and Modern approachChhaya Sawant
Updated version of Diagnostic Microbiology - Traditional and Modern approach. The presentation is an overview of conventional techniques still used in many laboratories and new technologies such as Molecular- and Protein-based testing
Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...QIAGEN
Antibiotic resistant strains of pathogenic bacteria are a growing worldwide health problem. To effectively combat the spread of difficult-to-treat bacterial infections, rapid surveillance methods for detection of antibiotic resistance genes is required to monitor both bacterial isolates and metagenomic samples. Additionally, identification of potential new sources for different antibiotic resistance genes is critical. Both of these goals require tools that can be used for profiling of antibiotic resistance genes from various types of samples. Real-time PCR has proven to be effective for the detection of antibiotic resistance genes. Using PCR array technology, simultaneous detection of 87 prevalent and important antibiotic resistance genes is possible and should prove to be an effective method for antibiotic resistance monitoring. This allows for a more comprehensive profiling of antibiotic resistance genes than is possible using individual PCR assays.
Tuberculosis is a raging problem round the globe. Eradicating TB is a herculean task but is possible is efforts from all corners from the world. The diagnostics have taken a big leap and with effective medications, our dream of TB free world may come true. But unlimited efforts are need to reach our goal.
Diagnostic Medical Microbiology - Traditional and Modern approachChhaya Sawant
Updated version of Diagnostic Microbiology - Traditional and Modern approach. The presentation is an overview of conventional techniques still used in many laboratories and new technologies such as Molecular- and Protein-based testing
Diagnosis of tuberculosis by direct demonstration of the pathogen or by indirect demonstration of cell mediated immunity through activation of CD 4 and / or CD 8 T lymphocytes.
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxPathKind Labs
Hepatitis B Virus and Hepatitis C Virus infections are transmitted by parentral route. Early diagnosis and treatment can prevent cirrhosis of liver in HCV cases as drugs which can cure the infection are now available.
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxPathKind Labs
Many changes have been made recently in Tuberculosis. The first important change is that instead of control now the focus is on eradication. for that to happen we need to change the way we detect, diagnose and treat tuberculosis.
Catridge based nucleic acid amplification test(CBNAAT) / RIF assay gene xpert POWER PONT. other normal tests versus CBNAAT. issues for cbnaat by WHO & CONCLUSION.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Importance of real time pcr in diagnosis of infectious diseases
1. IMPORTANCE OF MOLECULAR
METHODS IN DIAGNOSIS OF
INFECTIOUS DISEASES – A Special
emphasis on Real Time PCR
Maj (Dr) Shilpi Gupta
Graded Specialist (Microbiology)
4. What are the available
options for Laboratory
Diagnosis?
5. LAB DIAGNOSIS OF INFECTIOUS DISEASES
MICROSCOPY
Gram Stain
ZN Stain
Fluorescence
stain
Electron
Microscopy
CULTURE
TECHNIQUES
Solid
Liquid
SEROLOGICAL
METHODS
Agglutination
Precipitation
ELISA
NUCLEIC ACID
AMPLIFICATION TEST
LAMP
PCR
Real Time PCR
OTHER
Biochemical
tests
TST/ Mantoux
test
Adenosine
Deaminase
(ADA)
6. Advantages of Molecular over conventional
methods
Molecular Conventional
Rapid (1h – 1 day) Days to month
More sensitive Less sensitive
More specific Less specific
Less laborious Laborious, requires manpower
Less chances of contamination Chances of contamination more
Quantification possible Qualitative
8. Conventional PCR & Real Time PCR
Conventional PCR Real Time PCR
Semi-automated Totally automated
5-6 hrs to complete one test 1hrs or <1 hr for one test
Less sensitive, specific and reproducible
than REAL TIME
Most specific, sensitive , reliable and
reproducible
Requires sophisticated infrastructure Lesser space
9.
10. POINT OF CARE TESTING (POCT)
Point-of-care testing (POCT): is defined as medical testing
at or near the site of patient care
• Simple, Automated & Easy to
read
• Independent power source
• Cost effective • Long shelf life reagents
• Microfluidic (less sample) • Short sample processing time
• Quantitative • High sensitivity and specificity
• Portable or near patient
diagnosis
• No need of skilled trained lab
technician
11. POCT (list)
Generation Methods Examples
First generation Rapid Detection tests (RDTs) Dengue, Chikungunya,
Hepatitis A, B, C, E
Second generation Cartridge based NAAT (CB NAAT) GeneXpert (MTB, H1N1, HIV,
HBV, HCV)
Third generation Hand held portable chip based
Real Time NAAT
TrueNat (HBV, HCV, Dengue,
Chikungunya, Malaria, HPV)
Pai, N.P
., et al. 2012, PLOS Medicine
Pai, N.P and Pai, M. Discovery medicine 2012
12. EVOLUTION OF NAAT: From reference lab
to Point-of-care
NAAT
• RT PCR
CB-NAAT
• Gene Xpert
• Xpert MTB/RIF
POCT
• Real time micro
system
16. ADVANTAGES OF TrueNAT over Xpert MTB/RIF
Xpert MTB/RIF TrueNAT
Method No step for removal of PCR
inhibitors
PCR inhibitors removed thus
increase positivity rate
Conditions for machine Non portable (bulky) system Potable
No battery backup Battery backup available
Strict temp conditions required Any temp
Senstivity & Specificity Slightly lesser Comparable or better
17. CASE SCENARIO
27 y/o male, HIV-negative, presented to a hospital with 2 months of
cough
CXR: “Diffuse micronodular pattern”
Treated for Community Acquired Pneumonia and discharged
Team did considered MTB
Sputum AFB smear-negative
Cultures pending
No Sputum molecular method done
Culture grew M. tuberculosis 1 month later
Already hospitalized at another hospital in ICU
Being treated for bacterial sepsis
He not only tested positive for TB, but had also developed MDR-TB
ATT is started, but patient passes away a few days later
18. Concerns in Diagnostics
Medical diagnostics take time, are costly and often give
inconclusive results.
Many doctors prefer to administer drugs on poor/average patients
on the basis of symptoms rather than recommending expensive
tests.
By the time the disease is diagnosed, patients turn resistant to the
drugs or their disease worsens.
19. Real Time PCR is most
specific, sensitive, rapid, reliable,
reproducible, POCT and extremely
powerful method among all types of diagnostic
modalities
20. RECOMMENDED TESTS FOR PUL & EPTB
CONDITION FREQUENCY SPECIMEN RECOMMENDED TESTS REMARKS
Pulmonary TB 75% Sputum • Liquid culture (Gold
standard)
• Real Time PCR
• In MDR suspected
cases molecular
method should be 1st
choice
Tubercular
lymphadenitis
35-40% Lymph node
aspirate
• Liquid culture (~70%
positivity)
• Real Time PCR
Pleural TB 20% Pleural fluid • Biochemical analysis
• ADA is useful screening
• IGRA may be helpful
• Liquid culture (~80%
positivity)
• Real Time PCR has
low sensitivity
• Smear microscopy
lower sensitivity
21. RECOMMENDED TESTS FOR PUL & EPTB Contd..
CONDITION FREQUENCY SPECIMEN RECOMMENDED TESTS REMARKS
Genitourinary
TB
10-15% Urine • Culture (80% positivity)
• Real Time PCR (90%
positivity)
• Culture negative pyuria with
acidic urine
• 75% patients have abnormal
CXR
• 3 morning urine samples
collected (~100 ml)
Males Prostatic
secretion
• Culture (~40% positivity)
• Real Time PCR (~36%
positivity)
• Leucocyturia and hematuria
are seen in ~50%
Females Endometrial
biopsy tissue
Menstrual blood
Pelvic fluid
• Real Time PCR (~30%
positivity)
• Culture (~40% positivity)
• Patient present with infertility,
pelvic pain, menstrual
disorders
Potts disease 10% Pus drained
from abscess
Synovial fluid
Bone biopsy
• Culture
• Histology
• Radiological (CT MRI) reveals
characteristic lesions
22. RECOMMENDED TESTS FOR PUL & EPTB Contd..
CONDITION FREQUENCY SPECIMEN RECOMMENDED TESTS REMARKS
Tubercular
meningitis
5% CSF • Biochemical analysis
• Real Time PCR (~ 70%
positivity)
• Culture (~ 80 %
• Negative result does not
exclude diagnosis of
TBM
Tubercular
peritonitis
3.5% Ascitic fluid • Biochemical analysis
• Culture (low sensitivity)
• Peritoneal biopsy (by
laparoscopy) is often
needed to establish the
diagnosis
Tubercular
pericarditis
Very low Pericardial
fluid
• Biochemical analysis
• Culture (~ 70% positivity)
• ADA
• IFN Y assay
• Disease of elderly with
low TB prevalence
• Seen in HIV +ve
23. HEPATITIS B INFECTION
• Acute: Initial infection with the hepatitis B virus
Mild or Severe
• Chronic: Hepatitis B virus remains in the blood for more
than 6 months or for years CARRIERS
Recovery or Chronic hepatitis
(9 of 10) (1 of 10)
Why Chronic Hepatitis B is dangerous?
Chronic
Hepatitis B
Liver
cirrhosis
Liver
failure
Liver
cancer
25. Algorithm for diagnosis of Hep B in Jaundice
patients
HBV
HBsAg
Reactive Non-reactive
IgM Anti HBc
Reactive
If HbsAg is Reactive and lgM anti HBc is Nonreactive: HBV positive
If lgM Anti HBc is Reactive and HBsAg is Nonreactive: HBV positive
If both Reactive: HBV positive
If both Non-reactive: HBV negative
Non-reactive
National Laboratory Guidelines for Testing of Viral Hepatitis,2018 MOHFW
26. Algorithm for diagnosis of Hep B in patients without
Jaundice
HBV
HBsAg
Reactive
Report: HBV
Positive
Non-
Report: HBV
Negative
National Laboratory Guidelines for Testing of Viral Hepatitis,2018 MOHFW
28. Role of HBV DNA
Most sensitive index of viral replication
Better marker of level of viraemia as compared to HBeAg
HBV detection based on Real Time PCR approach can detect
as few as 10² – 10³ genome copies.
Useful in following the course of HBV replication in patients
with chronic hep B receiving antiviral chemotherapy
Patients with HBV pre-core mutant are HBeAg negative and
HBV DNA positive
29. OCCULT HEPATITIS B INFECTION
Occult Hepatitis B: Infection with detectable HBV DNA and
undetectable surface antigen (HBsAg) in blood (very low levels
(invariably <200 IU/mL).
Most are also anti-HBc positive.
HBV DNA amplification by Real Time PCR is a gold standard assay for
detection & quantification of Occult HBV infection.
2011, World J Gastroenterology
30.
31. HEPATITIS C INFECTION
Fibrosis1
Chronic HCV
infection can lead to
the development of
fibrous scar tissue
within the liver
Fibrosis Cirrhosis Hepatocellular Carcinoma
(with cirrhosis)
Cirrhosis1,2
Over time, fibrosis can progress,
causing severe scarring of the
liver, restricted blood flow,
impaired liver function, and
eventually liver failure
HCC3
Cancer of the liver can
develop after years of
chronic HCV infection
32. Total
No.
Infected
(millions)
Diagnosed
Undiagnosed
2.7 to 5 Million1
75% Unaware of Infection
1.1 Million1
21% Unaware of Infection
~800,000 to 1.4 Million1
65% Unaware of Infection
HIV HBV HCV
4
3
2
1
0
Prevalence of Chronic Viral Infections
HCV is Nearly 4 Times as Prevalent as HIV and HBV
• A 2011 study estimated that as many as 5.2 million persons are
living with HCV in the United States2
HBV=hepatitis B virus; HCV=hepatitis C virus; HIV=human immunodeficiency virus.
1. Institute of Medicine. Washington, DC: The National Academies Press; 2010.
2. Chak E, et al. Liver Int. 2011;31(8):1090-1101.
3. Gish Hepatology 2015
33. Algorithm for diagnosis of Hep C in patients with or
without Jaundice
HCV
Anti HCV
Reactive
Report: *HCV Ab Positive
Non-reactive
Report: HCV Ab Negative
*Should be followed by testing for HCV RNA using NAT (RT-PCR) for confirmation
If HCV RNA is detected: current/active HCV infection
If HCV RNA is not detected: Past, resolved infection or false HCV antibody positivity
34. Method Screen Confirm
Duration
of therapy
Assessing
treatment
response
HCV antibody test
(ELISA)
X
PCR: HCV genotype X
Real Time PCR:
HCV RNA
X X
Australian Government National Hepatitis C Testing Policy 2007. Available at: http://www.health.gov.au
36. What causes Malaria?
Malaria is caused by Plasmodium of which 4 species infect humans.
-P. vivax
-P. ovale
-P. malariae
-P. falciparum :causes the most severe form of malaria
Cerebral malaria
Acute renal failure
Acute respiratory distress syndrome (ARDS)
Severe anaemia (Hb < 5g%)
Hemoglobinuria
Hypotension, Shock
Hyperpyrexia
Hemolysis
37. DIAGNOSIS
•Fever, Chills,
Headache,
Malaise, Vomiting,
Diarrhea, jaundice,
Body & Joint Pain
CLINICAL
• Technical and expert skill
required
• Early infection parasite
not detected
• Qualitative
MICROSCOPY
• False negative results
• overall sensitivity of <
81%.
• Cross reactivity with
rheumatoid factor
RDT RT PCR
• Most specific,
sensitive , reliable
and reproducible
• Exact quantification
of DNA in sample
40. LAB DIAGNOSIS
Method Detection Test
Antigen
detection
Detect the NS1 antigen RDT, ELISA, Real Time PCR
Antibody
detection
Detect IgM and IgG
antibodies
RDT, ELISA
Viral isolation Grows virus Viral culture
41.
42.
43. LAB DIAGNOSIS
Virus isolation
Must only be carried in Level-3 laboratories
Results can take between 1-2 weeks.
Real Time PCR
Rapid
Reliable
Specific
44. Human Papilloma Virus (HPV)
More than 100 types of HPV, of which atleast 14 are cancer
causing.
Two HPV types (16 and 18) cause 70% of cervical cancers
and pre-cancerous cervical lesions.
Cervical cancer is the second most common cancer in
women in developing countries.
45. PREVENTION
PRIMARY SECONDARY TERTIARY
Girls 9-14 yrs Women 30 years old or older All women as needed
HPV vaccination Screen and treat Treatment of invasive cancer
at any age
Health and sex education 1. HPV testing for high risk
HPV types – POCT
2. Visual inspection with
Acetic acid (VIA)
3. PAP test and liquid based
cytology (LBC)
Surgery
Radiotherapy
Chemotherapy
Palliative
Condom promotion Followed by treatment
Male circumcision
46. abnormal cells in micropscope
CxCa Prevention (screening)
When positive triage, diagnosis, therapy
1) PAP smear
2) HPV Test
High-risk HPV16,18,31,33,…
Low-risk HPV6, 11, 42,…..
47. Take Home Message
Conventional Microbiological diagnostic methods are time taking
and inconclusive at times
Advance Molecular methods are rapid, specific and most reliable in
current scenario
To date Real Time PCR is the only available method for diagnosis in
certain conditions
Slide 23. The role of testing in diagnosis and treatment
The HCV antibody test (Enzyme Immune Assay; EIA), which is used to detect the presence of anti-HCV, is the usual initial test for patients with clinical liver disease and is also acceptable for screening at-risk patients.
To confirm the diagnosis, testing for serum HCV ribonucleic acid (RNA) by sensitive polymerase chain reaction (PCR) amplification is recommended.
Prior to initiating treatment in patients infected with chronic hepatitis C, it is important to determine the patient’s baseline viral load with a quantitative assay as well as their HCV genotype. HCV genotype determines the length of therapy.
While on treatment, patients’ progress can be monitored by determining the presence of HCV RNA, with a quantitative PCR assay. At the end of treatment and at follow-up a qualitative test will confirm the absence of HCV replication.